In accordance with its contribution to motility and invasion of several cancers (van Golen et al, 2000b; He et al, 2008), our data show that RhoC contributes to tumour progression by affecting invasion, anoikis resistance, tumour growth and angiogenesis in cervical carcinoma cell lines. This evidence concerns the gene RHOC and neoplasm.